| dc.identifier.citation | Anonim, 2003, Beberapa Tanaman yang Berkhasiat Sebagai Antikanker, InfoPOM, 4(6): 1-3. Backer, C.A., Brink, V.D.R.C., 1965, Flora of Java, Volume I, N.V.P. Noordhoff, Groningen, The Netherlands. Chiang, H. C., Jaw, S.M., Chen, C.F., Kan, W.s., 1992, Antitumor agent from Physalis angulata L., Anticancer Res, 12(3):837. Freshney, R. I., 1986, Culture of Animal Cells : A Manual of Basic Technique, Fourth Ed. A John Willey and Sons, Inc. Publication, New York, USA. Foster, J. S., Henley, D. C., Ahamed, S., and Wimalasena, J., 2001, Estrogen and cell cycle regulation in breast cancer, Trend in Endocrin. and Metabolism, 12(7), 320-327. Hanahan, D. and Weinberg, R.A., 2000, The hallmark of cancer, Cell, 100, 57-70. Hsieh, W.T., Huang, K.Y., Lin, H.Y., Chung, J, G., 2006, Physalis angulata induced G2/M phase arrest in human breast cancer cells, Food and chemical toxicology. Ismail, N., and Alam, M., 2001, A novel cytotoxic flavonoid glycoside from Physalis angulata, Fitoterapi, vol. 72, 676-679. Julia, S., 2001, Uji Sitotoksisitas Fraksi Protein Daun Erytrhina fusca lour (Cangkring) pada sel HeLa, Skripsi, Fakultas Farmasi, UGM, Yogjakarta King, R.J.B., 2000, Cancer Biology, 2nd ed., Pearson Education Limited, London. Lin, Y.S., Chiang, H.C., Kam, W.S., Shih, S.L., and Won, M.H., 1992, Immunomodulatory activity of Various fractions derived from Phisalys angulata L extract, Aim J Chin Med, 20 (3-4):233-243. Ma’at, S., 1999, Pengujian Bioaktivitas Tanaman Obat sebagai Antikanker, Program Pasca Sarjana Universitas Indonesia Airlangga, Surabaya. Maryati dan Sutrisna, EM., 2007, Potensi antiproliferatif tanaman ceplukan (Physalis angulata L) terhadap sel Myeloma, Laporan Hibah Penelitian, Fakultas Farmasi, Universitas Muhammadiyah Surakarta. Meiyanto, E., 2002, Biologi Molekuler, Buku Ajar, Proyek QUE Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta. Robens, 2000, http://www.geocities.com/j_robens/index.html diakses pada Mei 2003. Sherr, C.J. 1996, Cancer cell cycles, Science, 274, 1672-1677. Sledge Jr., G.W. and Miller, K.D., 2003, Review exploiting the hallmarks of cancer: the future conquest of breast cancer, Eur. J. Cancer, 39, 1668– 1675. Sudarsono, Gunawan, D., Wahyono, S., Donatus, I.A., 2002, Tumbuhan Obat II, Hasil Penelitian, Sifat-sifat dan Penggunaan, Pusat Studi Obat Tradisional UGM, 147-150. Tjindarbumi, D. and Mangunkusumo, R., 2002, Cancer in Indonesia, present and future, Jpn. J. Clin. Oncol., 32(Supplement 1), S17-S21. Wyllie, A., Donahue, V., Fischer, B., Hill, D., Keesey, J., and Manzow, S., 2000, Cell Death Apoptosis and Necrosis, Rosche Diagnostic Corporation. Yaroslavsky, B., Watkin, S., Donennberg, A.D., Patton, T.J., and Steinman, R.A., 1999, Subelluler and cell Cycle Expression Profiles of CDK-Inhibitor in Normal Differentiating Myeloid Cells, Blood, 93, 2907-2917. Zhang, B., Gojo, I., and Fenton, R.G., 2002, Myeloid Cell Factor-1 is a critical Survival factor For Multiple HeLa, Blood, 99(6), 1885-1893. | en_US |
